BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8530006)

  • 1. Direct molecular analysis of the fragile X syndrome in a sample of Egyptian and German patients using non-radioactive PCR and Southern blot followed by chemiluminescent detection.
    el-Aleem AA; Böhm I; Temtamy S; el-Awady M; Awadalla M; Schmidtke J; Stuhrmann M
    Hum Genet; 1995 Nov; 96(5):577-84. PubMed ID: 8530006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expand Long PCR for fragile X mutation detection.
    Hećimović S; Barisić I; Müller A; Petković I; Barić I; Ligutić I; Pavelić K
    Clin Genet; 1997 Sep; 52(3):147-54. PubMed ID: 9377803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of Fragile X syndrome by Southern blot hybridization using a chemiluminescent probe: a laboratory protocol.
    Gold B; Radu D; Balanko A; Chiang CS
    Mol Diagn; 2000 Sep; 5(3):169-78. PubMed ID: 11070151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test.
    Brown WT; Houck GE; Jeziorowska A; Levinson FN; Ding X; Dobkin C; Zhong N; Henderson J; Brooks SS; Jenkins EC
    JAMA; 1993 Oct; 270(13):1569-75. PubMed ID: 8371467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population.
    Snow K; Doud LK; Hagerman R; Pergolizzi RG; Erster SH; Thibodeau SN
    Am J Hum Genet; 1993 Dec; 53(6):1217-28. PubMed ID: 7902673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of the (CGG)n expansion in the FMR-1 gene in 59 Spanish fragile X syndrome families.
    Milà M; Kruyer H; Glover G; Sánchez A; Carbonell P; Castellví-Bell S; Volpini V; Rossell J; Gabarrón J; López I
    Hum Genet; 1994 Oct; 94(4):395-400. PubMed ID: 7927336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the human fragile X mental retardation 1 polymerase chain reaction reagents to amplify the FMR1 gene: testing in a clinical diagnostic laboratory.
    Nahhas FA; Monroe TJ; Prior TW; Botma PI; Fang J; Snyder PJ; Talbott SL; Feldman GL
    Genet Test Mol Biomarkers; 2012 Mar; 16(3):187-92. PubMed ID: 21992462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput analysis of fragile X (CGG)n alleles in the normal and premutation range by PCR amplification and automated capillary electrophoresis.
    Larsen LA; Grønskov K; Nørgaard-Pedersen B; Brøndum-Nielsen K; Hasholt L; Vuust J
    Hum Genet; 1997 Oct; 100(5-6):564-8. PubMed ID: 9341871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple fragile X PCR assay with 7-deazaguanine-substituted DNA visualized by ethidium bromide.
    Cao J; Tarleton J; Barberio D; Davidow LS
    Mol Cell Probes; 1994 Apr; 8(2):177-80. PubMed ID: 7935515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-radioactive DNA diagnosis for the fragile X syndrome in mentally retarded Japanese males.
    Nanba E; Kohno Y; Matsuda A; Yano M; Sato C; Hashimoto K; Koeda T; Yoshino K; Kimura M; Maeoka Y
    Brain Dev; 1995; 17(5):317-21; discussion 323-4. PubMed ID: 8579216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragile X CGG repeat variation in Tamil Nadu, South India: a comparison of radioactive and methylation-specific polymerase chain reaction in CGG repeat sizing.
    Indhumathi N; Singh D; Chong SS; Thelma BK; Arabandi R; Srisailpathy CR
    Genet Test Mol Biomarkers; 2012 Feb; 16(2):113-22. PubMed ID: 22023245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A methylation PCR approach for detection of fragile X syndrome.
    Panagopoulos I; Lassen C; Kristoffersson U; Aman P
    Hum Mutat; 1999; 14(1):71-9. PubMed ID: 10447261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymerase chain reaction analysis of fragile X mutations.
    Erster SH; Brown WT; Goonewardena P; Dobkin CS; Jenkins EC; Pergolizzi RG
    Hum Genet; 1992; 90(1-2):55-61. PubMed ID: 1427787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A genetic and molecular study of 85 families affected with the fragile X syndrome].
    Milà Recasens M; Sánchez Díaz A; Glover López G; Castellví Bel S; Carbonell Meseguer P; Kruyer H; Ballesta Martínez F; Estivill Pallejà X
    An Esp Pediatr; 1996 Mar; 44(3):250-6. PubMed ID: 8830601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular diagnosis of fragile X syndrome with polymerase chain reaction: application of a diagnostic protocol in 50 families from northern Spain].
    Durán Domínguez M; Molina Carrillo M; Fernández Toral J; Martínez Merino T; López Arístegui MA; Alvarez Retuerto AI; Onaindía Urquijo ML; Tejada Mínguez MI
    An Esp Pediatr; 2001 Apr; 54(4):331-9. PubMed ID: 11273816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved sizing of fragile X CCG repeats by nested polymerase chain reaction.
    Levinson G; Maddalena A; Palmer FT; Harton GL; Bick DP; Howard-Peebles PN; Black SH; Schulman JD
    Am J Med Genet; 1994 Jul; 51(4):527-34. PubMed ID: 7943035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategy for reliable prenatal detection of normal male carriers of the fragile X syndrome.
    Halley D; Van Den Ouweland A; Deelen W; Verma I; Oostra B
    Am J Med Genet; 1994 Jul; 51(4):471-3. PubMed ID: 7943022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved fluorescent PCR-based assay for sizing CGG repeats at the FRAXA locus.
    Houdayer C; Lemonnier A; Gerard M; Chauve C; Tredano M; de Villemeur TB; Aymard P; Bonnefont JP; Feldmann D
    Clin Chem Lab Med; 1999 Apr; 37(4):397-402. PubMed ID: 10369109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution methylation polymerase chain reaction for fragile X analysis: evidence for novel FMR1 methylation patterns undetected in Southern blot analyses.
    Chen L; Hadd A; Sah S; Houghton JF; Filipovic-Sadic S; Zhang W; Hagerman PJ; Tassone F; Latham GJ
    Genet Med; 2011 Jun; 13(6):528-538. PubMed ID: 21430544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pseudo-full mutation identified in fragile X assay reveals a novel base change abolishing an EcoRI restriction site.
    Liang S; Bass HN; Gao H; Astbury C; Jamehdor MR; Qu Y
    J Mol Diagn; 2008 Sep; 10(5):469-74. PubMed ID: 18687789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.